Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes.
about
Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier SystemNovel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice.Pathogenesis of kidney disease in systemic lupus erythematosus.Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus.Use of ultrasound to assess renal reperfusion and P-selectin expression following unilateral renal ischemiaTargeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Targeted delivery of therapeutics to endothelium.Innovations in studying in vivo cell behavior and pharmacology in complex tissues--microvascular endothelial cells in the spotlight.siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNAHuman anti-α3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis.Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies.Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytesNew short interfering RNA-based therapies for glomerulonephritis.Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts.Progression of renal fibrosis: the underestimated role of endothelial alterations.A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.Diverse origins of the myofibroblast—implications for kidney fibrosis.Renal allograft fibrosis: biology and therapeutic targets.Targeted endothelial nanomedicine for common acute pathological conditions.Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.Nanomedicines for renal disease: current status and future applicationsPeptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.E-selectin-targeted Sialic Acid-PEG-dexamethasone Micelles for Enhanced Anti-Inflammatory Efficacy for Acute Kidney InjuryP-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation.Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.Endothelium-targeted delivery of dexamethasone by anti-VCAM-1 SAINT-O-Somes in mouse endotoxemia.
P2860
Q28548472-60F50D96-CBD8-4098-80F6-15512B95FF4BQ30427986-C7DDA048-0985-4E2D-ACC1-B6F88687057BQ30434907-6D2AED78-44F5-4CC1-8B2B-C7C006A9B048Q30437707-96465CF8-867C-4DC2-8067-94C6A71E6376Q30447632-E4AA4A73-3F11-4616-B537-6D28683FDFFFQ30466992-2E4AA860-2209-410F-BDFB-BFB685713959Q30475849-FDBB58E7-DDD8-4A68-BDDF-E58AE61F0E7EQ35000486-738D2084-CA16-4220-BF56-4F386BB43F41Q35224125-DDDE05CC-F4EE-4DDE-8602-0DF508157D6BQ36174495-E26BD5BA-85AA-448C-8675-FF57DE3A1232Q37221480-2CCE2F5B-5B5D-4FDB-B649-96828E5BE1E9Q37714138-E2297DB7-C7C1-4BAE-AA36-8C1A0303CF93Q37879444-DA4DD8B8-62A8-4D6B-8C06-C9D75D0681EBQ37902117-A0E23F66-E872-4F9E-8241-644D1E4DC503Q38069231-24F1AFBA-9717-49EC-A02C-7E15C47B22AEQ38145567-994BAC78-586A-43FA-AD33-E24C93AC3319Q38316792-5BFE329A-2266-40DA-8755-BDB8C594AC69Q38359455-BA535F16-4233-41E6-889E-A53361DB5A94Q38598987-A24A36B4-1755-48B5-A3BD-690B93BC00AAQ38650120-4B79A789-9B15-487D-9400-B837BAA93CD3Q38802375-CE6EC889-D95F-4B6A-A33B-A38A1E5870A4Q39314491-305EA17B-AD85-48FC-82E9-9A4400B40492Q40980366-9DEAC5B7-34EF-4BA0-8E48-7C3DDB023D26Q41200749-F3139A6A-1A2D-47B3-852C-216AB7E63CF0Q41548278-9C5461BF-32FE-4E7C-BD71-98DF0313558CQ54253305-E3571834-AA24-40D6-9921-3C94D7F534EC
P2860
Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@ast
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@en
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@nl
type
label
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@ast
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@en
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@nl
prefLabel
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@ast
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@en
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@nl
P2093
P2860
P1476
Inhibition of proinflammatory ...... asone-loaded AbEsel liposomes.
@en
P2093
Hendrik E Moorlag
Henriëtte W Morselt
Hester I Bakker
Jan A A M Kamps
Jan Willem Kok
Peter Heeringa
Peter J Zwiers
Sigrídur A Asgeirsdóttir
P2860
P304
P356
10.1152/AJPRENAL.00391.2007
P577
2007-12-26T00:00:00Z